Connect with us

Media & Technology

Astra Veda Corporation (OTCMKTS: ASTA) Blue Sky Breakout as its Joint Venture to Manufacture Bullet BarrierTM Products Gains Traction

Published

on

Astra Veda Corporation (OTCMKTS: ASTA) is moving northbound with power in recent days having surpassed previous highs the stock is now on a blue-sky breakout. ASTA is quickly emerging as a volume leader in small caps attraction legions of new shareholders including some heavy hitters on the OTC. Currently under heavy accumulation ASTA is moving steadily northbound with many new investors buying in every day. ASTA is looking to blaze a path along the likes of Enzolytics or Tesoro and break out into a whole new dimension – Tesoro went to multi dollars – and ASTA has much stronger fundamentals then Tesoro ever did. 

There are big things happening at Astra Veda as the Company’s capable management team works hard behind the scenes getting their filings up to date in an effort to go to “pink current” Punchzee is a joint venture development effort between Paranotek, LLC and a group of private investors. Punchzee is a disruptive data-driven project management and team communication platform for the construction industry, property management companies and home developers and inspectors. Punchzee currently manages over 100,000 critical life, safety and fire certification and inspection tasks for companies throughout the eastern United States, including the NYPD and hospital systems through the area. Recently ASTA formed a jv to manufacture Bullet BarrierTM Products.  The new entity is called Ballistic Barrier Products Inc. (BBP), and responsible for product development, manufacturing and sales support for ballistic resistant window and door coverings fulfilling the incredible demand for orders. A facility has already been identified in the heart of the textile industry in the Southeastern US with close regional support for materials, equipment, and skilled labor.   

Astra Veda Corporation (OTCMKTS: ASTA) operating out of Aurora, Colorado co-founds technology companies and incubate them to maturity to generate revenue for Astra and its partners. The Company builds winning products in a capital-efficient way, using design thinking, lean startup and agile development methodologies. 

ASTA operating subsidiaries are Paranotek; a global innovation company focused on developing mobile apps and licensing robust technologies that increase personal and corporate information privacy through breakthrough advancements in encryption. Paranotek began as a Finnish technology and design company working together with US partners. Paranotek has developed a disruptive and future-proof encryption technology called Parano™ that can be integrated into existing software and apps for everyday life. 

Punchzee is a joint venture development effort between Paranotek, LLC and a group of private investors. Punchzee is a disruptive data-driven project management and team communication platform for the construction industry, property management companies and home developers and inspectors. Punchzee currently manages over 100,000 critical life, safety and fire certification and inspection tasks for companies throughout the eastern United States, including the NYPD and hospital systems through the area. 

https://twitter.com/BrianWalton78/status/1422020873062600706

https://twitter.com/HokieMaverick/status/1422280963598528522

To Find out the inside Scoop on ASTA Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

ASTA

ASTA has a strong management team behind it; the Company’s CEO James M. Davis a high-level executive who played a key rose in the founding of High-Speed Access Corporation contributing to the more than Two-Billion-dollar initial public offering on NASDAQ. A year later, the company was later purchased by Charter Communications owned by Microsoft co-founder Paul Allen. In addition to his academic achievements in Cognitive Human Behavior from the University of Maine, he maintains an active Top-Secret clearance from the US government. Mick continues advising government agencies on a variety of confidential initiatives as a highly compensated expert (HCE). 

The Company’s operating officer Jeff Ballard, who before joining ASTA was brought in to reorganize and reimagine the IT operations for Hudson Pacific Properties, the $5B US West Coast real estate investment trust and the largest owner of independent movie studios in the US. Prior to Hudson Pacific, Jeff drove corporate-wide, multimillion dollar initiatives for companies such as Honda, SDI Media, Colorado Access, United Health (Pacificare Health Systems) and Stewart Title. Lauri Tunnela, Ron MacDonald, and Johannes Maliranta round off Astra Veda management team. 

On May 27 Astra Veda Corporation Chief Executive Mick Davis announced that a substantial investment has been made in a joint venture to manufacture Bullet BarrierTM Products.  The new entity is called Ballistic Barrier Products Inc. (BBP), and responsible for product development, manufacturing and sales support for ballistic resistant window and door coverings fulfilling the incredible demand for orders. 

A facility has been identified in the heart of the textile industry in the Southeastern US with close regional support for materials, equipment, and skilled labor.  BBP will be selling to residential and commercial customers as well as schools and government entities both domestically and abroad in the coming months. Partners in the venture include Astra Veda Corporation, Egres Enterprises and Rift Management Inc. (RMI).  Astra is focused on co-founding technology companies and incubate them to success.  

ASTA CEO James M. Davis stated:  “We are following through on our long-term strategy of creating products and services for cyber security and life protection industries by investing in Bullet BarrierTM . Our team in Finland with its quantum computing resistant encryption and Sayphr™  platform are examples of this leadership directive”, Davis continued.  Funding, financial oversight and corporate governance are the primary responsibilities of Astra in the partnership. 

https://twitter.com/WzCkiD/status/1422567388558495748

For More on ASTA Subscribe Right Now!

Astra Ved is moving northbound with power in recent days having surpassed previous highs the stock is now on a blue-sky breakout. ASTA is quickly emerging as a volume leader in small caps attraction legions of new shareholders including some heavy hitters on the OTC. Currently under heavy accumulation ASTA is moving steadily northbound with many new investors buying in every day. ASTA is looking to blaze a path along the likes of Enzolytics or Tesoro and break out into a whole new dimension – Tesoro went to multi dollars – and ASTA has much stronger fundamentals then Tesoro ever did.There are big things happening at Astra Veda as the Company’s capable management team works hard behind the scenes getting their filings up to date in an effort to go to “pink current” Punchzee is a joint venture development effort between Paranotek, LLC and a group of private investors. Punchzee is a disruptive data-driven project management and team communication platform for the construction industry, property management companies and home developers and inspectors. Punchzee currently manages over 100,000 critical life, safety and fire certification and inspection tasks for companies throughout the eastern United States, including the NYPD and hospital systems through the area. Recently ASTA formed a jv to manufacture Bullet BarrierTM Products.  The new entity is called Ballistic Barrier Products Inc. (BBP), and responsible for product development, manufacturing and sales support for ballistic resistant window and door coverings fulfilling the incredible demand for orders. A facility has already been identified in the heart of the textile industry in the Southeastern US with close regional support for materials, equipment, and skilled labor.  We will be updating on ASTA when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with ASTA.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in TXTM either long or short and we have not been compensated for this article.

 

On other matters, the Astra Veda compliance team is still working with FINRA and OTC Markets providing information for financial filings. The Company continues to remediate securities defects and engage in legal action holding the previous goverance to a full accounting.
Astra Veda Corporation (OTCMKTS: ASTA) operating out of Aurora, Colorado co-founds technology companies and incubate them to maturity to generate revenue for Astra and its partners. The Company builds winning products in a capital-efficient way, using design thinking, lean startup and agile development methodologies.
ASTA operating subsidiaries are Paranotek; a global innovation company focused on developing mobile apps and licensing robust technologies that increase personal and corporate information privacy through breakthrough advancements in encryption. Paranotek began as a Finnish technology and design company working together with US partners. Paranotek has developed a disruptive and future-proof encryption technology called Parano™ that can be integrated into existing software and apps for everyday life.
Punchzee is a joint venture development effort between Paranotek, LLC and a group of private investors. Punchzee is a disruptive data-driven project management and team communication platform for the construction industry, property management companies and home developers and inspectors. Punchzee currently manages over 100,000 critical life, safety and fire certification and inspection tasks for companies throughout the eastern United States, including the NYPD and hospital systems through the area.
ASTA has a strong mangement team behind it; the Company;s CEO James M. Davis a high level executive who played a key rose in the founding of High-Speed Access Corporation contributing to the more than Two Billion-dollar initial public offering on NASDAQ. A year later, the company was later purchased by Charter Communications owned by Microsoft co-founder Paul Allen. In addition to his academic achievements in Cognitive Human Behavior from the University of Maine, he maintains an active Top Secret clearance from the US government. Mick continues advising government agencies on a variety of confidential initiatives as a highly compensated expert (HCE).
The Company’s operating officer Jeff Ballard, who before joining ASTA was brought in to reorganize and reimagine the IT operations for Hudson Pacific Properties, the $5B US West Coast real estate investment trust and the largest owner of independent movie studios in the US. Prior to Hudson Pacific, Jeff drove corporate-wide, multi million dollar initiatives for companies such as Honda, SDI Media, Colorado Access, United Health (Pacificare Health Systems) and Stewart Title. Lauri Tunnela, Ron MacDonald, and Johannes Maliranta round off Astra Veda management team.
On May 27 Astra Veda Corporation Chief Executive Mick Davis announced that a substantial investment has been made in a joint venture to manufacture Bullet BarrierTM Products. The new entity is called Ballistic Barrier Products Inc. (BBP), and responsible for product development, manufacturing and sales support for ballistic resistant window and door coverings fulfilling the incredible demand for orders.
A facility has been identified in the heart of the textile industry in the Southeastern US with close regional support for materials, equipment, and skilled labor. BBP will be selling to residential and commercial customers as well as schools and government entities both domestically and abroad in the coming months. Partners in the venture include Astra Veda Corporation, Egres Enterprises and Rift Management Inc. (RMI). Astra is focused on co-founding technology companies and incubate them to success.
ASTA CEO James M. Davis stated: “We are following through on our long-term strategy of creating products and services for cyber security and life protection industries by investing in Bullet BarrierTM . Our team in Finland with its quantum computing resistant encryption and Sayphr™ platform are examples of this leadership directive”, Davis continued. Funding, financial oversight and corporate governance are the primary responsibilities of Astra in the partnership.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Featured

LAVA Therapeutics (NASDAQ: LVTX) Gammabody™ Platform Gains Momentum

Published

on

LAVA Therapeutics N.V. (NASDAQ: LVTX) shares soared 106% as the company announced that Janssen Biotech, Inc. chose a lead candidate.

LAVA Therapeutics N.V. (NASDAQ: LVTX) shares soared 106% as the company announced that Janssen Biotech, Inc., a part of the Janssen Pharmaceutical Companies of Johnson & Johnson, chose a lead candidate aimed at an undisclosed tumor-associated antigen for further development towards clinical settings.

GAMMABODY™ PLATFORM

LAVA primarily focuses on revolutionizing cancer therapy by developing its Gammabody™ platform. This platform enables them to create bispecific gamma delta T cell engagers that can activate a specific subset of gamma-delta T cells called Vγ9Vδ2 (Vgamma9 Vdelta2) T cells. By utilizing this approach, they aim to enhance the natural recognition of tumors, guide Vγ9Vδ2 T cells to target the tumor cells directly and trigger a cascade of immune responses.

To Discover the Inside Scoop on LVTX, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

What sets their Gammabody™ drug candidates apart is their exceptional performance and safety profiles observed in preclinical studies. Compared to other bispecific T cell engager approaches, their candidates have demonstrated superior efficacy and preferred targeting tumor cells. This targeted approach has the potential to minimize toxicity in healthy tissues.

In May 2020, LAVA entered into a research collaboration and license agreement with Janssen, a subsidiary of the Janssen Pharmaceutical Companies of Johnson & Johnson. This collaboration aimed to discover and develop novel bispecific antibody-based gamma delta T cell engagers for cancer treatment. The agreement was facilitated by Johnson & Johnson Innovation, emphasizing their commitment to fostering innovation in the field.

As part of the collaboration, LAVA had the opportunity to receive potential milestone payments and royalties based on the successful development, regulatory approvals, and commercialization of the candidates. This incentivized LAVA to actively pursue the discovery and advancement of promising lead candidates. 

The collaboration represents a remarkable milestone many early-stage biotech companies aspire to achieve. Partnering with a program brings numerous benefits, including reduced risk of dilution through milestone payments as the trials advance and streamlined commercialization once the product receives approval.

Under the terms of the agreement, Janssen will assume responsibility for the selected candidate’s future clinical development, manufacturing, and commercialization. This includes bearing the costs and expenses associated with these activities.

Stephen Hurly, LAVA Therapeutics’s president and chief executive officer, expressed satisfaction with Janssen’s selection of a lead candidate for clinical studies. He emphasized LAVA’s pioneering role in developing gamma-delta bispecific antibodies through their proprietary Gammabody platform. This platform and LAVA’s extensive expertise in bispecific antibody development position them at the forefront of advancing novel therapies for cancer patients.

In summary, LAVA Therapeutics’ collaboration with Janssen has reached a significant milestone in selecting a lead candidate for further development toward clinical studies. This progress underscores LAVA’s dedication to leveraging its Gammabody platform and expertise in bispecific antibody development to revolutionize cancer treatment.

We will update you on LVTX when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Continue Reading

Featured

Onfolio Holdings (NASDAQ: ONFO) Unleashing the Power of AI

Published

on

Onfolio Holdings Inc (NASDAQ: ONFO), a technology services company, has recently introduced an advanced generative AI search function for its subsidiary, MightyDeals.com.

Onfolio Holdings Inc (NASDAQ: ONFO), a technology services company, has recently introduced an advanced generative AI search function for its subsidiary, MightyDeals.com. The implementation of this innovative AI tool, powered by chatGPT-style Large Language Models (LLMs), has resulted in a surge of 105% in the company’s stock price and sparked tons of investor interest. The company has a 3.28M float and, at the time of writing, has traded 20x that amount, with a colossal 60M shares exchanging hands.

Revolutionizing User Experience and Driving Stock Surge

With the integration of AI search on MightyDeals.com, customers can now use natural language to describe the products they seek, simplifying the buying process. The AI tool utilizes contextual understanding and description analysis of hundreds of active deals to generate instant search results based on users’ queries. By enhancing the user experience, Onfolio Holdings anticipates increased user return rates, higher site interaction rates, and elevated revenues for MightyDeals.com. This groundbreaking development has attracted positive attention, significantly increasing Onfolio Holdings’ stock price.

To Discover the Inside Scoop on ONFO, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Evaluating Financial Performance

While the stock surge indicates investor enthusiasm, assessing Onfolio Holdings’ financial performance is crucial for comprehensive investment analysis. The positive earnings growth of +44.44% and revenue growth of +22.74% contribute to the company’s optimistic outlook. However, investors should be cautious of the negative net profit margin of -190.75% and the lack of available price/book ratio data. Monitoring the company’s financial performance leading up to the next reporting date on August 30, 2023, is advised to understand its profitability and overall stability better.

Investment Outlook and Future Prospects

Considering the stock surge and optimistic price forecasts, Onfolio Holdings has promising prospects. Analysts offer a median target price of $3.00 for the company’s stock, signaling an expectation of significant growth within the next 12 months. However, it is essential to note that Onfolio Holdings operates at a loss. Investors should thoroughly evaluate the company’s long-term growth potential and weigh the potential returns against the inherent risks before making investment decisions.

About MightyDeals.com

Mighty Deals is a free daily deals website aimed at creative professionals focusing on products and services for web designers and developers. The site offers fantastic deals on quality fonts, templates, apps, add-ons, plug-ins, ebooks, icons, and more. The site provides discounts on packages which usually range between 50%-97% off but are only available for a limited time. MightyDeals.com boasts an exceptional return rate from its users and is one of Onfolio Holdings’ highest revenue-generating subsidiaries.

About Onfolio Holdings Inc.

Onfolio acquires and manages a diversified portfolio of online businesses across a broad range of verticals, each with a niche content focus and brand identity. Onfolio acquires firms that meet its investment criteria, being that such businesses operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by our existing team or have strong management teams largely in place. The Company excels at finding acquisition opportunities where the seller has not fully optimized their business. Onfolio’s experience and skillset allow it to add increased value to these existing businesses.

Conclusion

Onfolio Holdings’ introduction of the generative AI search function for MightyDeals.com has increased the company’s stock price, reflecting the market’s positive response to this innovative technology. The enhanced user experience and the potential for increased revenues have positioned Onfolio Holdings as a leader in the tech industry. However, investors must carefully consider the company’s financial performance and evaluate its long-term growth potential before making investment decisions. Monitoring the company’s performance to the next reporting date will provide valuable insights into its financial health and stability.

We will update you on ONFO when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by James from Pixabay

Continue Reading

Featured

Enveric Biosciences (NASDAQ: ENVB) Pioneering the Future of Anxiety Disorder Treatment

Published

on

Enveric Biosciences, Inc. (NASDAQ: ENVB) shares surged 78% this morning upon approval of some fantastic news.

Enveric Biosciences, Inc. (NASDAQ: ENVB) shares surged 78% this morning upon approval of some fantastic news. The United States Patent and Trademark Office has granted them a notice of allowance for their patent application concerning a groundbreaking chemical compound called EB-373. This compound is being developed to address the treatment of anxiety disorders.

The forthcoming patent, titled “C4-Carbonothioate-Substituted Tryptamine Derivatives and Methods of Using,” encompasses claims for the composition of matter of a family of revolutionary prodrug derivatives of psilocin. Enveric’s lead product candidate, EB-373, stands out among these derivatives. A Notice of Allowance signifies that the USPTO has determined that a patent should be granted based on the submitted application.

To Discover the Inside Scoop on ENVB, Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Enveric’s commitment to innovation extends beyond EB-373. They have also submitted additional patent applications to the USPTO, exploring psilocin prodrugs with unique crystalline molecular structures. Moreover, they have taken proactive steps to pursue global coverage of the EVM201 and EVM301 Series through companion Patent Cooperation Treaty and non-US national patent applications. Encouragingly, positive International Search Reports and written opinions have been received under the Patent Cooperation Treaty for most of these applications.

Joseph Tucker, Ph.D., Enveric’s director and CEO, underlined the significance of the USPTO’s favorable decision concerning their lead candidate, EB-373. He highlighted the innovative designs of their psilocin prodrugs within the EVM201 series, differentiating them from conventional counterparts like psilocybin. These novel designs hold the potential to deliver more rapid therapeutic effects, precise control, and reduced gastrointestinal side effects. Tucker emphasized that securing a robust intellectual property portfolio for their new chemical entity prodrugs is pivotal to Enveric’s value proposition and integral to their business strategy of developing cutting-edge small-molecule therapeutics to address mental health disorders.

We will update you on ENVB when more details emerge, so make sure you are subscribed to Microcapdaily to know what’s happening in the markets!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Image by Gino Crescoli from Pixabay

Continue Reading

Trending

© All rights reserved.

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.